Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Tech Daily Utah.
Press releases published on June 9, 2025
Nutanix to Host Tech Talk on Cloud Native Capabilities
GlobeNewswire
·
June 9, 2025
SAN JOSE, Calif., June 09, 2025 (GLOBE NEWSWIRE) -- Nutanix, Inc. (NASDAQ: NTNX), a leader in hybrid multicloud computing, today announced that it will host a webinar to discuss the cloud native capabilities of the Nutanix Cloud Platform, including Nutanix …
Beacon Therapeutics Strengthens Leadership Team with the Appointment of Dr. Daniel Chung as Chief Medical Officer
GlobeNewswire
·
June 9, 2025
LONDON and CAMBRIDGE, Mass., June 09, 2025 (GLOBE NEWSWIRE) -- Beacon Therapeutics Holdings Limited (‘Beacon Therapeutics’ or ‘the Company’), a leading clinical-stage biotechnology company with a mission to save and restore the vision of patients with …
RTI to Host Expert Panel on Edge-to-Cloud Connectivity for AI and Autonomy
GlobeNewswire
·
June 9, 2025
SUNNYVALE, Calif., June 09, 2025 (GLOBE NEWSWIRE) -- Real-Time Innovations (RTI), the software framework company for physical AI systems, will host a live webinar on June 24, 2025, titled Real-Time Data Anywhere: Powering Edge AI and Cloud with Data- …
Results from Humacyte’s V007 Pivotal Phase 3 AV Access Study Highlighted by Presentation at the Society for Vascular Surgery Meeting
GlobeNewswire
·
June 9, 2025
DURHAM, N.C., June 09, 2025 (GLOBE NEWSWIRE) -- Humacyte, Inc. (Nasdaq: HUMA), a commercial-stage biotechnology platform company developing universally implantable, bioengineered human tissue at commercial scale, announced today that the results from its …
PDS Biotech to Host Key Opinion Leader Event to Discuss Versamune® HPV for the Treatment of HPV16+ HNSCC
GlobeNewswire
·
June 9, 2025
Event to Discuss the Changing Landscape of HNSCC in context with the Merck KN-689 study and the Rapidly Increasing Incidences of HPV16-positive HNSCC in the United States and Europe Webinar to be held Tuesday, June 17, 2025, 12:00 PM ET PRINCETON, N.J., …
BitMine Immersion Technologies, Inc. Buys 100 Bitcoin in First Purchase of Company Bitcoin Treasury Strategy
GlobeNewswire
·
June 9, 2025
LAS VEGAS, June 09, 2025 (GLOBE NEWSWIRE) -- BitMine Immersion Technologies, Inc. (“BitMine” and the “Company”) (NYSE American: BMNR), a technology company focused on the accumulation of Bitcoin for long-term investment, whether acquired by their Bitcoin …
DN Miner Empowers Crypto Holders to Earn During Sideways Markets with AI-Powered Cloud Mining
GlobeNewswire
·
June 9, 2025
London, UK , June 09, 2025 (GLOBE NEWSWIRE) -- With major digital assets like Bitcoin and Solana entering consolidation phases, crypto holders are searching for ways to unlock the potential of their portfolios without relying solely on price appreciation. …
Tired of the cryptocurrency hype? Join SIX MINING and earn passive income — without the guesswork!
GlobeNewswire
·
June 9, 2025
Washington, D.C, June 09, 2025 (GLOBE NEWSWIRE) -- The crypto market is full of hype, sudden pumps, and unpredictable dumps—like Trump Coin’s recent 7% jump that still can’t shake its overall bearish outlook. If you're tired of chasing trends and getting …
Free Mining with BCCMINING: Dogecoin, Bitcoin and Litecoin
GlobeNewswire
·
June 9, 2025
Atlanta, Georgia, June 09, 2025 (GLOBE NEWSWIRE) -- Free Mining with BCCMINING: Dogecoin, Bitcoin and Litecoin BCC Mining, a new member of the cryptocurrency community, recently launched a new mobile app, which is undoubtedly great news for cloud mining …
Earn Mining: Turn your phone into a mining machine, automatically earn BTC/DOGE/LTC every day, and obtain high fixed potential income through mobile cloud mining
GlobeNewswire
·
June 9, 2025
Vancouver, Canada, June 09, 2025 (GLOBE NEWSWIRE) -- With the rapid development of artificial intelligence, the wave of cryptocurrency has gradually swept the world. In this era driven by new technologies, traditional mining machines can no longer meet …
Palvella Therapeutics Receives Initial Proceeds from FDA Orphan Products Grant to Support Phase 3 SELVA Trial of QTORIN™ Rapamycin for Microcystic Lymphatic Malformations
GlobeNewswire
·
June 9, 2025
FDA Orphan Products Grants are awarded based on rigorous scientific and technical review by rare disease and regulatory experts Up to $2.6 million in non-dilutive funding anticipated over the grant period Top-line data from SELVA expected in the first …
LeddarTech Enters into Further Amendments to Credit Facility and Bridge Financing Offer and Announces the Return to Work of Certain Employees Following Furlough
GlobeNewswire
·
June 9, 2025
QUEBEC CITY, Canada, June 09, 2025 (GLOBE NEWSWIRE) -- LeddarTech® Holdings Inc. (“LeddarTech” or the “Company”) (Nasdaq: LDTC), an automotive software company that provides patented disruptive AI-powered low-level sensor fusion and perception software …
LeddarTech apporte d’autres modifications à sa facilité de crédit et à son offre de financement relais et annonce le retour au travail de certains employés mis à pied
GlobeNewswire
·
June 9, 2025
QUÉBEC, Canada, 09 juin 2025 (GLOBE NEWSWIRE) -- LeddarTech® Holdings Inc. (« LeddarTech » ou la « Société ») (Nasdaq : LDTC), une société de logiciels automobiles qui fournit des technologies logicielles de fusion bas niveau de capteurs et de perception …
PolyPid Announces Positive Topline Results from Phase 3 SHIELD II Trial: D-PLEX₁₀₀ Demonstrated Significant Reduction in Surgical Site Infections and Successfully Met Primary and All Key Secondary Endpoints
GlobeNewswire
·
June 9, 2025
D-PLEX100 successfully met the primary efficacy endpoint, with statistically significant results (p<0.005) in 798 patients with large abdominal surgery incisions. The trial successfully met all key secondary efficacy endpoints, including a 58% reduction in …
Alarum Technologies Updates Second Quarter 2025 Revenue and Adjusted EBITDA Outlook
GlobeNewswire
·
June 9, 2025
TEL AVIV, Israel, June 09, 2025 (GLOBE NEWSWIRE) -- Alarum Technologies Ltd. (Nasdaq, TASE: ALAR) (“Alarum” or the “Company”), a global provider of web data collection solutions, today announced an update to its revenue and Adjusted EBITDA outlook for the …
Outbrain Completes Change of Corporate Name to Teads
GlobeNewswire
·
June 9, 2025
NEW YORK, June 09, 2025 (GLOBE NEWSWIRE) -- Outbrain Inc. (NASDAQ: OB), which is operating under the new Teads brand following Outbrain’s acquisition of Teads in February 2025, announced today that the combined company has completed its corporate renaming …
Oddity Finance LLC Announces Proposed $350 Million Offering of 0% Exchangeable Senior Notes Due 2030
GlobeNewswire
·
June 9, 2025
As of March 31, 2025, ODDITY had $257 million in cash, and an undrawn $200 million credit line Capital raise gives ODDITY additional firepower to play offense and pursue future opportunities in a volatile world A portion of the proceeds will be used to …
George Medicines announces FDA approval of WIDAPLIK™ (telmisartan, amlodipine and indapamide), a new single pill combination treatment for hypertension in adults, including initial treatment
GlobeNewswire
·
June 9, 2025
Novel, single pill, triple combination with a standard dose and two lower doses that can deliver the efficacy benefits of combination therapy, with an established safety profile and good tolerability First and only triple combination for the initial …
Bio-Path Holdings to Present at Life Sciences Virtual Investor Forum
GlobeNewswire
·
June 9, 2025
HOUSTON, June 09, 2025 (GLOBE NEWSWIRE) -- Bio-Path Holdings, Inc., (OTC:BPTH), a biotechnology company leveraging its proprietary DNAbilize® liposomal delivery and antisense technology to develop a portfolio of targeted nucleic acid cancer and obesity …
NewAmsterdam Pharma Announces Positive Topline Alzheimer’s Disease Data from BROADWAY Clinical Trial
GlobeNewswire
·
June 9, 2025
-- Pre-specified analyses show that obicetrapib treatment leads to statistically significant and clinically meaningful reductions in the primary outcome measure of Alzheimer’s disease biomarker in both the full ITT population (p<0.002) and in ApoE4 …